Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Massimo Puoti and Roberto Fumagalli.
Massimo Puoti
Connection Strength
0.396
Roberto Fumagalli
  1. Neurological manifestations in patients hospitalized with COVID-19: A retrospective analysis from a large cohort in Northern Italy. Eur J Neurosci. 2021 04; 53(8):2912-2922.
    View in: PubMed
    Score: 0.059
  2. Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy. Nat Commun. 2021 01 19; 12(1):434.
    View in: PubMed
    Score: 0.058
  3. Effectiveness of infection-containment measures on SARS-CoV-2 seroprevalence and circulation from May to July 2020, in Milan, Italy. PLoS One. 2020; 15(11):e0242765.
    View in: PubMed
    Score: 0.057
  4. Detection and quantification of SARS-CoV-2 by droplet digital PCR in real-time PCR negative nasopharyngeal swabs from suspected COVID-19 patients. PLoS One. 2020; 15(9):e0236311.
    View in: PubMed
    Score: 0.056
  5. Safety and efficacy of anti-il6-receptor tocilizumab use in severe and critical patients affected by coronavirus disease 2019: A comparative analysis. J Infect. 2020 10; 81(4):e11-e17.
    View in: PubMed
    Score: 0.056
  6. Persistent positivity and fluctuations of SARS-CoV-2 RNA in clinically-recovered COVID-19 patients. J Infect. 2020 Sep; 81(3):e90-e92.
    View in: PubMed
    Score: 0.056
  7. Successful recovery from severe COVID-19 pneumonia after kidney transplantation: The interplay between immunosuppression and novel therapy including tocilizumab. Transpl Infect Dis. 2020 Oct; 22(5):e13334.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.